NDC 67877-474 Dabigatran Etexilate
Capsule, Coated Pellets Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 67877 - Ascend Laboratories, Llc
- 67877-474 - Dabigatran Etexilate
Product Characteristics
WHITE (C48325 - LIGHT CREAM OPAQUE)
19 MM
DAB;75
Product Packages
NDC Code 67877-474-60
Package Description: 60 CAPSULE, COATED PELLETS in 1 BOTTLE
Price per Unit: $6.35864 per EA
Product Details
What is NDC 67877-474?
What are the uses for Dabigatran Etexilate?
What are Dabigatran Etexilate Active Ingredients?
- DABIGATRAN ETEXILATE MESYLATE 75 mg/1 - A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.
Which are Dabigatran Etexilate UNII Codes?
The UNII codes for the active ingredients in this product are:
- DABIGATRAN ETEXILATE MESYLATE (UNII: SC7NUW5IIT)
- DABIGATRAN (UNII: I0VM4M70GC) (Active Moiety)
Which are Dabigatran Etexilate Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
- HYDROXYPROPYL CELLULOSE (TYPE L) (UNII: UKE75GEA7F)
- CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
- POVIDONE K25 (UNII: K0KQV10C35)
- TALC (UNII: 7SEV7J4R1U)
- TARTARIC ACID (UNII: W4888I119H)
- HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) (UNII: 87Y6436BKR)
- POLYETHYLENE GLYCOL 600 (UNII: NL4J9F21N9)
- HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)
- POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- POLYVINYL ALCOHOL (UNII: 532B59J990)
- METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A (UNII: NX76LV5T8J)
- SODIUM BICARBONATE (UNII: 8MDF5V39QO)
- D&C RED NO. 33 (UNII: 9DBA0SBB0L)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
- SHELLAC (UNII: 46N107B71O)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- AMMONIA (UNII: 5138Q19F1X)
What is the NDC to RxNorm Crosswalk for Dabigatran Etexilate?
- RxCUI: 1037045 - dabigatran etexilate 150 MG Oral Capsule
- RxCUI: 1037045 - dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule
- RxCUI: 1037179 - dabigatran etexilate 75 MG Oral Capsule
- RxCUI: 1037179 - dabigatran etexilate 75 MG (as dabigatran etexilate mesylate 86.48 MG) Oral Capsule
Which are the Pharmacologic Classes for Dabigatran Etexilate?
* Please review the disclaimer below.
Patient Education
Dabigatran
Dabigatran is used to treat deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in adults and children 3 months of age and older who have been treated with an injectable anticoagulant ('blood thinner'). It is also used to reduce the risk of a DVT and PE from happening again after initial treatment is completed in adults and children 3 months of age and older. Dabigatran is used to help prevent DVT and PE in adults who have had hip replacement surgery. Dabigatran is also used to help prevent strokes or serious blood clots in adults who have atrial fibrillation (a condition in which the heart beats irregularly, increasing the chance of clots forming in the body, and possibly causing strokes) without heart valve disease. Dabigatran is in a class of anticoagulant medications called direct thrombin inhibitors. It works by preventing blood clots from forming in the body.
[Learn More]
Blood Thinners
What are blood thinners?
Blood thinners are medicines that prevent blood clots from forming. They do not break up clots that you already have. But they can stop those clots from getting bigger. It's important to treat blood clots, because clots in your blood vessels and heart can cause heart attacks, strokes, and blockages.
Who needs blood thinners?
You may need a blood thinner if you have:
- Certain heart or blood vessel diseases
- An abnormal heart rhythm called atrial fibrillation
- A heart valve replacement
- A risk of blood clots after surgery
- Congenital heart defects
What are the different types of blood thinners?
There are different types of blood thinners:
- Anticoagulants, such as heparin or warfarin (also called Coumadin), slow down your body's process of making clots.
- Antiplatelets, such as aspirin and clopidogrel, prevent blood cells called platelets from clumping together to form a clot. Antiplatelets are mainly taken by people who have had a heart attack or stroke.
How can I take blood thinners safely?
When you take a blood thinner, follow the directions carefully. Blood thinners may interact with certain foods, medicines, vitamins, and alcohol. Make sure that your health care provider knows all of the medicines and supplements you are using.
You may need regular blood tests to check how well your blood is clotting. It is important to make sure that you're taking enough medicine to prevent clots, but not so much that it causes bleeding.
What are the side effects of blood thinners?
Bleeding is the most common side effect of blood thinners. They can also cause an upset stomach, nausea, and diarrhea.
Other possible side effects can depend on which type of blood thinner that you are taking.
Call your provider if you have any sign of serious bleeding, such as:
- Menstrual bleeding that is much heavier than normal
- Red or brown urine
- Bowel movements that are red or black
- Bleeding from the gums or nose that does not stop quickly
- Vomit that is brown or bright red
- Coughing up something red
- Severe pain, such as a headache or stomachache
- Unusual bruising
- A cut that does not stop bleeding
- A serious fall or bump on the head
- Dizziness or weakness
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".